“In the absence of structural heart disease….” What is it, and why does it matter in antiarrhythmic drug therapy?

This publication has 29 references indexed in Scilit:

• Proarrhythmic effects of antiarrhythmic drugs: Evolving concepts
  American Heart Journal, 1992
• Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease
  The American Journal of Cardiology, 1991
• Recent advances in understanding the mechanisms of drug-induced torsades de pointes arrhythmias
  The American Journal of Cardiology, 1989
• Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy.
  Circulation, 1989
• Arrhythmogenic effects of antiarrhythmic drugs: A study of 506 patients treated for ventricular tachycardia or fibrillation
  Journal of the American College of Cardiology, 1989
• The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
  Progress in Cardiovascular Diseases, 1988
• Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing
  Journal of the American College of Cardiology, 1988
• Aggravation of arrhythmia by antiarrhythmic drugs—Incidence and predictors
  The American Journal of Cardiology, 1987
• Clinical types of proarrhythmic response to antiarrhythmic drugs
  The American Journal of Cardiology, 1987
• Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
  Circulation, 1982